Precise dispensing technologies to advance diagnostic solutions
28 Aug 2024
Join Rob Rich, Director of Sales, America at BioDot, as he introduces the innovative Omnia™ system. Learn about BioDot's mission and core expertise, the inspiration behind Omnia, and its standout features and benefits. Discover how this cutting-edge system, with its precise dispensing technology, is transforming diagnostics and making a significant impact in various applications including the manufacturing of synthetic DNA oligos, high-throughput screening, and biochip and biosensor point of care diagnostic devices. The Omnia system is the only platform on the market that combines two dispensing technologies, offering a large dynamic dispensing volume range.
This video was filmed at ADLM 2024.
About the company

BioDot Inc.
BioDot aims to become the principle supplier of sub-microliter dispense systems (for the manufacture of micro-array and microfluidic devices) to Molecular Diagnostics, Theranostics and other emerging markets. This is driven by on-going technology development programs delivering Dispensing Innovation products like BioJet Plus. This unique non-contact nanoliter dispenser delivers genuine on the fly deposition of small drop volumes for high throughput production of Biosensors, BioChips and Protein/Cell arrays.
BioDot is already established as world leader in the supply of equipment and technology for the development and manufacture of membrane Rapid Diagnostic Tests and Biosensors.
BioDot enables, inspires, and educates scientists to commercialize their ideas from R&D through to manufactured product.








